3,4-dihydroxybenzohydroxamic acid has been researched along with Anemia, Sickle Cell in 1 studies
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaul, DK | 1 |
| Kollander, R | 1 |
| Mahaseth, H | 1 |
| Liu, XD | 1 |
| Solovey, A | 1 |
| Belcher, J | 1 |
| Kelm, RJ | 1 |
| Vercellotti, GM | 1 |
| Hebbel, RP | 1 |
1 other study available for 3,4-dihydroxybenzohydroxamic acid and Anemia, Sickle Cell
| Article | Year |
|---|---|
Robust vascular protective effect of hydroxamic acid derivatives in a sickle mouse model of inflammation.
Topics: Anemia, Sickle Cell; Animals; Benzamidines; Blood Coagulation; Cell Communication; Chronic Disease; | 2006 |